Safety Shot ( (SHOT) ) has issued an update.
On March 4, 2025, Safety Shot, Inc. announced the publication of a peer-reviewed clinical trial in the Journal of Nutrition and Dietary Supplements, demonstrating the efficacy of Safety Shot® in reducing alcohol effects and hangover symptoms. This study, the first of its kind in humans, showed significant reductions in blood and breath alcohol levels and improved hangover symptoms, positioning Safety Shot® as a potential leader in the growing hangover cure market, which is projected to expand significantly by 2032.
More about Safety Shot
Safety Shot, Inc. is a wellness and dietary supplement company known for developing Sure Shot, a patented product designed to lower blood alcohol content and enhance clarity, energy, and mood. The company focuses on distributing Sure Shot to consumers and businesses, including retailers, restaurants, and bars, leveraging a blend of natural ingredients to support detoxification and wellness.
YTD Price Performance: -32.84%
Average Trading Volume: 801,244
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $35.27M
See more insights into SHOT stock on TipRanks’ Stock Analysis page.